Risk sharing agreements soar as market access risk increases
Pharmaceutical Technology
MARCH 17, 2023
Between 2012 and 2022, the number of oncology risk sharing agreements increased massively by 498%. Watt said risk sharing agreements in oncology made up almost 50% of all pharmaceutical risk sharing agreements, as per a GlobalData analysis. This may be because access to oncology drugs varies widely across the world, she added.
257 
Let's personalize your content